Table 1.
Characteristic | n |
---|---|
No. of patients | 111 |
Age, median (range), yr. | 50 (19 to 71) |
Female/male | 40/71 |
Histological Findings | |
Non-Hodgkins lymphoma | 70 |
Indolent | 17 |
Aggressive | 53 |
Hodgkin lymphoma | 12 |
Multiple myeloma | 16 |
AML/MDS | 4 |
CML | 3 |
Other | 6 |
No. of prior regimens, median (range) | 3 (0 to 7) |
Disease status at enrollment | |
Chemosensitive | 58 |
Chemoresistant | 51 |
CMV status of recipient | |
Negative | 48 |
Positive | 63 |
Minor ABO mismatch | 76 |
Major ABO mismatch | 22 |
Risk of relapse | |
Low | 23 |
Medium | 18 |
High | 66 |
AML indicates acute myelogenous leukemia; MDS, myelodysplastic syndrome; CML, chronic myelogenous leukemia; CMV, cytomegalovirus. Data are presented as n unless otherwise indicated.